RIKER LAUREN sold PCRX
October 8, 2026 · Form 4 insider transaction
RIKER LAUREN sold 6,000 shares of Pacira BioSciences, Inc. at $36.32 per share, a transaction worth $217.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,000
Price
$36.32
Total value
$217.9K
InsiderRIKER LAUREN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 8, 2026
Filing dateOctober 9, 2026
Shares owned after62,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.